Bill
A 5383
Requires unrestricted Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.
2024-2025 Regular Session
Introduced by Reginald Atkins and 6 co-sponsors
New Jersey bill mandates Medicaid coverage of ovulation-enhancing drugs and fertility services for infertile beneficiaries, expanding access but increasing state healthcare costs.
Received in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee